2 active not recruiting, 2 completed, 2 recruiting, 1 withdrawn. 4 Not applicable, 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Recruiting 2, Active not recruiting 1, Completed 1 |
| Phase 1 | 2 | Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Active not recruiting 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow placebo softgel: new trials by email Literature Review of placebo softgel trials Research Report on placebo softgel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Placebo Controlled, Parallel Virtual Clinical Trial to Investigate the Efficacy of Marine Oil Products on Omega-3 Status in Healthy Adults Omega-3 Softgel, Ultimate Omega Softgel, Ultimate Omega 2X Softgel - Omega 3 Index, Nutrient Status | Not applicable | Recruiting | Nordic Naturals | 600 | 2026-10-26 | 2026-10-28 |
| A Double-Blind, Randomized, Double-Dummy, Active and Placebo-Controlled Clinical Study to Assess the Effect of an Oral Skin Supplement on Skin Health in Healthy Adults Placebo SoftGel, Active SoftGel Supplement, Active Comparator Powder - Skin Aging | Not applicable | Recruiting | Amazentis SA | 90 | 2026-08-26 | 2026-09-22 |
| A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair. USPlus DERM Bioactive Fatty Acids 160 mg Softgels, Placebo softgel - Thinning Hair | Not applicable | Active not recruiting | Ablon Skin Institute Research Center | 60 | 2024-12-16 | 2025-04-10 |
| Tocotrienols for Skeletal Muscle Health placebo softgel, DeltaGold® Tocotrienol 70% - Dynapenia, Postmenopausal Women | Phase 1 / Phase 2 | Withdrawn | Texas Tech University Health Sciences Center | 2019-04-15 | 2022-02-18 | |
| Tocotrienols for Obesity of Postmenopausal Women placebo softgel, DeltaGold® Tocotrienol 70% - Obesity, Postmenopausal Women | Phase 1 / Phase 2 | Active not recruiting | Texas Tech University Health Sciences Center | 60 | 2019-03-15 | 2026-10-02 |
| THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease SPM Emulsion, Dose-modality, SPM Softgel, Dose-Modality, Placebo Softgel - Peripheral Arterial Disease, Claudication | Not applicable | Completed | University of California, San Francisco | 30 | 2016-03-01 | 2021-05-07 |
| The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia coenzyme Q10 vitamin E softgel, coenzyme Q10 softgel, placebo softgel - Dyslipidemia | Phase 3 | Completed | Sun Yat-sen University | 150 | 2015-07-01 | 2017-06-22 |
Alopecia (1) · Dyslipidemias (1) · Intermittent Claudication (1) · Obesity (1) · Osteoarthritis (1) · Peripheral Arterial Disease (1) · Vascular Calcification (1) · Vascular Diseases (1)
Texas Tech University Health Sciences Center (2) · Ablon Skin Institute Research Center (1) · Amazentis SA (1) · Nordic Naturals (1) · Sun Yat-sen University (1) · University of California, San Francisco (1)
United States (4) · Canada (1) · China (1) · India (1)
Chwan-Li Shen, PhD (2) · Dr. Mukta Sachdev, MD (1) · Glynis Ablon, MD, FAAD, PI (1) · Michael Conte, M.D. (1)
PMID 29454678, PMID 32152169, PMID 32696697, PMID 35241098, PMID 41319217